Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation
- PMID: 19438709
- DOI: 10.1111/j.1742-4658.2009.07061.x
Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation
Abstract
One of the most important pathological features of type 2 diabetes is the formation of islet amyloid, of which the major component is amylin peptide. However, the presence of a natural inhibitor such as insulin may keep amylin stable and physiologically functional in healthy individuals. Some previous studies demonstrated that insulin was a potent inhibitor of amylin fibril formation in vitro, but others obtained contradictory results. Hence, it is necessary to elucidate the effects of insulin on amylin aggregation. Here we report that insulin is a kinetic inhibitor of amylin aggregation, only keeping its inhibitory effect for a limited time period. Actually, insulin promotes amylin aggregation after long-term incubation. Furthermore, we found that this promotional effect could be attributed to the copolymerization of insulin and amylin. We also found that insulin copolymerized with amylin monomer or oligomer rather than preformed amylin fibrils. These results suggest that the interaction between insulin and amylin may contribute not only to the inhibition of amylin aggregation but also to the coaggregation of both peptides in type 2 diabetes.
Similar articles
-
Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.Biochem J. 2004 Feb 1;377(Pt 3):709-16. doi: 10.1042/BJ20030852. Biochem J. 2004. PMID: 14565847 Free PMC article.
-
Prevention and promotion effects of apolipoprotein E4 on amylin aggregation.Biochem Biophys Res Commun. 2008 Apr 4;368(2):414-8. doi: 10.1016/j.bbrc.2008.01.103. Epub 2008 Feb 1. Biochem Biophys Res Commun. 2008. PMID: 18243137
-
Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.Methods Cell Biol. 2008;90:267-86. doi: 10.1016/S0091-679X(08)00813-3. Methods Cell Biol. 2008. PMID: 19195555
-
Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.Diabete Metab. 1995 Feb;21(1):3-25. Diabete Metab. 1995. PMID: 7781840 Review.
-
Backbone-modified amylin derivatives: implications for amyloid inhibitor design and as template for self-assembling bionanomaterials.J Pept Sci. 2007 Nov;13(11):709-16. doi: 10.1002/psc.831. J Pept Sci. 2007. PMID: 17890652 Review.
Cited by
-
Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes.PLoS One. 2013;8(1):e54198. doi: 10.1371/journal.pone.0054198. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372685 Free PMC article.
-
Misfolded proteins in Alzheimer's disease and type II diabetes.Chem Soc Rev. 2012 Jan 21;41(2):608-21. doi: 10.1039/c1cs15112f. Epub 2011 Aug 4. Chem Soc Rev. 2012. PMID: 21818468 Free PMC article. Review.
-
Zinc and pH modulate the ability of insulin to inhibit aggregation of islet amyloid polypeptide.Commun Biol. 2024 Jun 27;7(1):776. doi: 10.1038/s42003-024-06388-y. Commun Biol. 2024. PMID: 38937578 Free PMC article.
-
Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions.J Am Chem Soc. 2014 Sep 17;136(37):12912-9. doi: 10.1021/ja504031d. Epub 2014 Sep 4. J Am Chem Soc. 2014. PMID: 25144879 Free PMC article.
-
Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin.Neurobiol Aging. 2016 Mar;39:19-24. doi: 10.1016/j.neurobiolaging.2015.11.005. Epub 2015 Dec 1. Neurobiol Aging. 2016. PMID: 26923398 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
